Getting in more steps may prevent the leading cause of disability in the US, study says
Getting your steps in is good for your health, but it may also help keep you from being affected by disability later, new research has found.
Walking 100 minutes a day was associated with a 23% reduced risk of chronic low back pain, according to a study published Friday in the journal JAMA Network Open.
'This is an important finding because walking is a simple, low cost, and accessible activity that can be promoted widely to reduce the burden of low back pain,' said lead study author Rayane Haddadj, a doctoral candidate in the department of public health and nursing at the Norwegian University of Science and Technology, in an email.
An estimated 600 million people worldwide experience low back pain, which is considered the leading cause of disability, said physiotherapist Dr. Natasha Pocovi, a postdoctoral research fellow in health sciences at Macquarie University in Sydney. She was not involved in the research.
By 2050, the number of people with chronic low back pain is expected to grow to 843 million, according to the World Health Organization.
And yet prevention of low back pain is often overlooked in research and clinical practice, Pocovi added.
The results from this latest study show there is the possibility of using physical activity as prevention. Pocovi said the research also 'suggests that we don't need to complicate our exercise routines to protect ourselves against chronic low back pain.'
To investigate the connection between walking and back pain prevention, the research team analyzed data from more than 11,000 participants age 20 and older from the Trøndelag Health, or HUNT, Study in Norway.
Between 2017 and 2019, HUNT researchers asked study participants to wear accelerometers for seven days to track their walking patterns. The HUNT team then followed up from 2021 and 2023 and asked if participants experienced back pain, according to the new study.
People were divided into four groups: those who walked less than 78 minutes in a day, 78 to 100 minutes, 101 to 124 minutes, and more than 125 minutes.
The findings showed that as the amount of daily walking increased, the risk of chronic low back pain decreased, and preliminary evidence revealed moderate or brisk walking was more protective than a slow pace, Pocovi said.
There are reasons to have confidence in the study results, including the large sample size and the use of accelerometers instead of people reporting their own levels of physical activity, she added.
However, the walking data was only captured over one week, which might not be reflective of people's patterns over a month or year, Pocovi said.
The study is also observational, which means that while it can show associations, researchers can't say for sure that the walking caused reduced risk of low back pain.
Not only is low back pain a leading cause of disability –– it's also expensive. On average, people spend more than $30,000 on back pain-related costs over the five years after first diagnosis, according to an April 2024 study.
Easy, inexpensive changes that prevent chronic low back pain can make a big difference, Haddadj said.
The study wasn't able to address if walking 100 minutes straight had more, less or the same impact as accumulating that same amount of time in short bursts, Pocovi said.
But in most cases, unless there is an underlying medical condition, any amount of walking is better than none, Pocovi said.
'Start with short walking sessions, either by planning specific walks or finding small ways to integrate a brief stroll into your daily routine,' she said.
She likes to take stairs instead of the elevator or walk to a coffee shop a little farther from her home, Pocovi said.
'The key is to gradually increase your walking in a sustainable and enjoyable way,' she said in an email. 'Additionally, it can be helpful to have a friend, partner, or colleague join you for walks to keep yourself motivated and accountable.'
You can add walking as a way to spend time with friends in addition to dinner and drinks, CNN fitness contributor Dana Santas, a certified strength and conditioning specialist and mind-body coach in professional sports, said in a previous article.
And if you want to move past getting a couple of extra steps and get more physical activity, you can still start small and build your way up, Santas said. Some workouts can even be completed from the comfort of your couch while watching an episode of your favorite TV show, she added.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Chicago Tribune
9 hours ago
- Chicago Tribune
Got the sniffles? Here's what to know about summer colds and the COVID-19 variant called stratus
Summer heat, outdoor fun … and cold and flu symptoms? The three may not go together in many people's minds: partly owing to common myths about germs and partly because many viruses really do have lower activity levels in the summer. But it is possible to get the sniffles — or worse — in the summer. Federal data released Friday, for example, shows COVID-19 is trending up in most states, with emergency department visits up among people of all ages. Here's what to know about summer viruses. The number of people seeking medical care for three key illnesses — COVID-19, flu and respiratory syncytial virus, or RSV — is currently very low, according to data from the Centers for Disease Control and Prevention. Flu is trending down and RSV has been steady. But COVID-19 is trending up in most U.S. states. Wastewater data from around the country estimates 'moderate' COVID-19 activity. CDC wastewater also shows the XFG variant — nicknamed stratus — is most common in the U.S. Stratus can cause a 'razor blade' sore throat and is considered a 'variant under monitoring' by the World Health Organization. The WHO said the variant is only marginally better at evading people's immune systems and vaccines still work against it. The expectation is that COVID-19 will eventually settle into a winter seasonal pattern like other coronaviruses, but the past few years have brought a late summer surge, said Dr. Dean Blumberg, chief of pediatric infectious diseases at University of California Davis Children's Hospital. Other viruses circulating this time of year include the one that causes 'hand, foot and mouth' disease — which has symptoms similar to a cold, plus sores and rashes — and norovirus, sometimes called the stomach flu. Many viruses circulate seasonally, picking up as the weather cools in the fall and winter. So it's true that fewer people get stuffy noses and coughs in the summer — but cold weather itself does not cause colds. It's not just about seasonality. The other factor is our behavior, experts say. Nice weather means people are opening windows and gathering outside where it's harder for germs to spread. But respiratory viruses are still around. When the weather gets too hot and everyone heads inside for the air conditioning, doctors say they start seeing more sickness. In places where it gets really hot for a long time, summer can be cold season in its own right. 'I grew up on the East Coast and everybody gets sick in the winter,' said Dr. Frank LoVecchio, an emergency room doctor and Arizona State University researcher. 'A lot of people get sick in the summer here. Why is that? Because you spend more time indoors.' For people who are otherwise healthy, timing is a key consideration to getting any vaccine. You want to get it a few weeks before that big trip or wedding, if that's the reason for getting boosted, doctors say. But, for most people, it may be worth waiting until the fall in anticipation of winter cases of COVID-19 really tick up. 'You want to be fully protected at the time that it's most important for you,' said Dr. Costi Sifri, of the University of Virginia Health System. People at higher risk of complications should always talk with their doctor about what is best for them, Sifri added. Older adults and those with weak immune systems may need more boosters than others, he said. Last month, the CDC noted emergency room visits among children younger than 4 were rising. That makes sense, Blumberg said, because many young kids are getting it for the first time or are unvaccinated. Health Secretary Robert F. Kennedy Jr. said in May that the shots would no longer be recommended for healthy kids, a decision that health experts have said lacks scientific basis. The American Academy of Pediatrics still endorses COVID-19 shots for children older than 6 months. The same things that help prevent colds, flu and COVID any other time of the year work in the summer, doctors say. Spend time outside when you can, wash your hands, wear a mask. And if you're sick, stay home.
Yahoo
12 hours ago
- Yahoo
Navamedic gains approval for Flexilev in OraFID packaging in Nordic countries
Navamedic has secured final approval for the Flexilev in OraFID tablet dispenser packaging material in the national languages of Norway, Sweden, and Denmark. OraFID is a patented, entirely mechanical medical device designed to deliver exact amounts of mini tablets to patients with a simple mechanism operated by a few twists of the hands. The company received the first approval of OraFID as the primary package for a pharmaceutical product in June 2025. The product licensor, Orion Corporation, has also received final confirmation for the Finnish market. Navamedic CEO Kathrine Gamborg Andreassen said: "We are excited to have received the last approvals, paving the way for our go-to-market launch in the Nordic region." The Flexilev in OraFID dispenser is designed to provide precise and personalised treatment for patients with Parkinson's, particularly advantageous for medications with a narrow therapeutic window. Hyper-fractionation, which involves administering smaller, more frequent doses, is made possible through this approach. Following the acquisition of Sensidose in May 2023, Flexilev, a novel prescription treatment for Parkinson's disease, became part of Navamedic's product range. The launch of OraFID in the Nordic markets is anticipated this October. Navamedic entered into a licensing and supply agreement with Orion for the distribution of Flexilev, which includes OraFID, across Europe in June 2024. This agreement excludes Sweden, Norway, Denmark, and Iceland, where Navamedic retains the rights to market and sell the product. Orion has secured the exclusive rights to market, distribute, and sell Flexilev in 27 European countries, including the five largest markets: Germany, France, Italy, Spain, and the UK. Orion acts as the marketing authorisation holder within its designated territory and will carry all associated rights and obligations. "Navamedic gains approval for Flexilev in OraFID packaging in Nordic countries" was originally created and published by Packaging Gateway, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

Associated Press
14 hours ago
- Associated Press
OpenEvidence creates the first AI in history to score a perfect 100% on the United States Medical Licensing Examination (USMLE)
MIAMI, Aug. 15, 2025 /PRNewswire/ -- Knowledge-based assessments remain a foundation of medical education. However, leveraging these resources for learning requires detailed and verifiable feedback to the medical student. To this aim, OpenEvidence has developed a new AI system that not only accurately answers each question on the United States Medical Licensing Examination (USMLE), but which also teaches the reasoning behind each answer—providing accurate references using gold-standard sources of medical knowledge such as the New England Journal of Medicine (NEJM) and the Journal of the American Medical Association (JAMA). OpenEvidence, a medical search platform that currently provides evidence-based clinical decision and practice support for over 40% of physicians in the United States, was the first to develop an AI system to score over 90% on the USMLE. OpenEvidence now becomes the first AI in history to score a perfect 100% on the United States Medical Licensing Examination (USMLE). Medical education remains costly with many inequalities in access to educational resources. OpenEvidence will be releasing a number of new AI models and other tools throughout this academic year to democratize access to quality medical education resources and support continued learning throughout training and clinical practice. These tools are built with a focus on education, creating vignettes for both knowledge recall and case based learning education, customizable by training level and grounded in the current medical literature. This achievement of becoming the first AI in history to score a perfect 100% on the USMLE is the result of a six-month effort to further evolve the core AI models and other technologies that power OpenEvidence, and demonstrates OpenEvidence's commitment and continued effort to improve physician knowledge at all levels of medical education. A question-by-question explanation—reasoned and written by OpenEvidence's AI system—of the correct answer to every single question on an official United States Medical Licensing Examination (USMLE) is linked here. View original content to download multimedia: SOURCE OpenEvidence